Scott Hadland

Last updated
Scott Hadland
Dr. Scott Hadland.jpg
Born (1981-11-19) November 19, 1981 (age 42)
Alma mater Harvard University
Washington University in St. Louis
Johns Hopkins University
McGill University
Scientific career
Fields pediatrics, adolescent medicine, addiction medicine, opioids, pharmaceutical marketing
Institutions Boston Children’s Hospital
Boston Medical Center
Harvard University
Website Boston University profile

Scott E. Hadland (born November 19, 1981) is a Canadian-American physician and scientist who serves as a pediatrician, and addiction specialist at Massachusetts General Hospital [1] [2] [3] and Harvard Medical School, where he is the Chief of the Division of Adolescent and Young Adult Medicine. [4] [5] He previously served as an addiction specialist at the Grayken Center for Addiction at Boston Medical Center. [6]

Contents

A key finding of Hadland's research has been to confirm that an increase in dollars spent on marketing from the pharmaceutical industry to American doctors was linked to mortality from opioid overdoses one year later. [7] [8] [9]

Research

A series of studies led by Hadland provide evidence linking the marketing of opioids directly to doctors, and the addiction epidemic in the United States. Counties where opioid manufacturers offered gifts and payments to doctors were found to have more overdose deaths involving prescription painkillers than counties where direct-to-physician marketing was less aggressive. [7] [8] The pharmaceutical industry spent $39.7 million promoting opioid medications to nearly 68,000 doctors from 2013 through 2015, including meals, trips and consulting fees. [7] For every three additional payments to doctors per 100,000 people in a county, overdose deaths involving prescription opioids in that area, a year later, were 18 percent higher.

In another study, Hadland showed that doctors participating in the national Medicare program who received drug company marketing of opioids prescribed on average 9% more opioids the next year compared to those who did not receive marketing. [10] In this study, which examined marketing in 2014, Insys Therapeutics was responsible for half of all marketing dollars to doctors. [10] The marketing practices of Insys were the subject of federal investigation in which Hadland’s study was cited, and its chief executive officer, John Kapoor, was convicted by a federal jury of racketeering conspiracy. [11] [12]

Hadland’s work has also examined drug company marketing of stimulant medications to treat attention deficit hyperactivity disorder (ADHD), [13] the effects of prescription drug monitoring programs on adolescent injection drug use, [14] and treatment for teens addicted to nicotine. [15]

Hadland’s writing on various health-related topics has appeared in USA Today, [16] [17] CNN [18] and Newsweek. [19] He has also appeared on CNN News to discuss COVID-19 related issues and quoted by ABC News. [20] [21]

Personal life

Hadland is married and lives in Boston with his husband, Jason Vassy, and two children. [4]

Related Research Articles

<span class="mw-page-title-main">Recreational drug use</span> Use of drugs with the primary intention to alter the state of consciousness

Recreational drug use is the use of one or more psychoactive drugs to induce an altered state of consciousness, either for pleasure or for some other casual purpose or pastime. When a psychoactive drug enters the user's body, it induces an intoxicating effect. Recreational drugs are commonly divided into three categories: depressants, stimulants, and hallucinogens.

<span class="mw-page-title-main">Substance abuse</span> Harmful use of drugs

Substance abuse, also known as drug abuse, is the use of a drug in amounts or by methods that are harmful to the individual or others. It is a form of substance-related disorder. Differing definitions of drug abuse are used in public health, medical, and criminal justice contexts. In some cases, criminal or anti-social behavior occurs when the person is under the influence of a drug, and long-term personality changes in individuals may also occur. In addition to possible physical, social, and psychological harm, the use of some drugs may also lead to criminal penalties, although these vary widely depending on the local jurisdiction.

<span class="mw-page-title-main">Harm reduction</span> Public health policies which lessen negative aspects of problematic activities

Harm reduction, or harm minimization, refers to a range of intentional practices and public health policies designed to lessen the negative social and/or physical consequences associated with various human behaviors, both legal and illegal. Harm reduction is used to decrease negative consequences of recreational drug use and sexual activity without requiring abstinence, recognizing that those unable or unwilling to stop can still make positive change to protect themselves and others.

Self-medication is a human behavior in which an individual uses a substance or any exogenous influence to self-administer treatment for physical or psychological conditions: for example headaches or fatigue.

<span class="mw-page-title-main">Opioid use disorder</span> Medical condition

Opioid use disorder (OUD) is a substance use disorder characterized by cravings for opioids, continued use despite physical and/or psychological deterioration, increased tolerance with use, and withdrawal symptoms after discontinuing opioids. Opioid withdrawal symptoms include nausea, muscle aches, diarrhea, trouble sleeping, agitation, and a low mood. Addiction and dependence are important components of opioid use disorder.

<span class="mw-page-title-main">Dextropropoxyphene</span> Withdrawn opioid medication

Dextropropoxyphene is an analgesic in the opioid category, patented in 1955 and manufactured by Eli Lilly and Company. It is an optical isomer of levopropoxyphene. It is intended to treat mild pain and also has antitussive and local anaesthetic effects. The drug has been taken off the market in Europe and the US due to concerns of fatal overdoses and heart arrhythmias. It is still available in Australia, albeit with restrictions after an application by its manufacturer to review its proposed banning. Its onset of analgesia is said to be 20–30 minutes and peak effects are seen about 1.5–2.0 hours after oral administration.

<span class="mw-page-title-main">Purdue Pharma</span> American pharmaceutical company (1892–2019 bankruptcy)

Purdue Pharma L.P., formerly the Purdue Frederick Company (1892–2019), was an American privately held pharmaceutical company founded by John Purdue Gray. It was sold to Arthur, Mortimer, and Raymond Sackler in 1952, and then owned principally by the Sackler family and their descendants.

<span class="mw-page-title-main">Substance abuse prevention</span> Measures to prevent the consumption of licit and illicit drugs

Substance abuse prevention, also known as drug abuse prevention, is a process that attempts to prevent the onset of substance use or limit the development of problems associated with using psychoactive substances. Prevention efforts may focus on the individual or their surroundings. A concept that is known as "environmental prevention" focuses on changing community conditions or policies so that the availability of substances is reduced as well as the demand. Individual Substance Abuse Prevention, also known as drug abuse prevention involves numerous different sessions depending on the individual to help cease or reduce the use of substances. The time period to help a specific individual can vary based upon many aspects of an individual. The type of Prevention efforts should be based upon the individual's necessities which can also vary. Substance use prevention efforts typically focus on minors and young adults – especially between 12–35 years of age. Substances typically targeted by preventive efforts include alcohol, tobacco, marijuana, inhalants, coke, methamphetamine, steroids, club drugs, and opioids. Community advocacy against substance use is imperative due to the significant increase in opioid overdoses in the United States alone. It has been estimated that about one hundred and thirty individuals continue to lose their lives daily due to opioid overdoses alone.

<span class="mw-page-title-main">Opioid overdose</span> Medical condition

An opioid overdose is toxicity due to excessive consumption of opioids, such as morphine, codeine, heroin, fentanyl, tramadol, and methadone. This preventable pathology can be fatal if it leads to respiratory depression, a lethal condition that can cause hypoxia from slow and shallow breathing. Other symptoms include small pupils, and unconsciousness; however, its onset can depend on the method of ingestion, the dosage and individual risk factors. Although there were over 110,000 deaths in 2017 due to opioids, individuals who survived also faced adverse complications, including permanent brain damage.

In the United States, prescription monitoring programs (PMPs) or prescription drug monitoring programs (PDMPs) are state-run programs which collect and distribute data about the prescription and dispensation of federally controlled substances and, depending on state requirements, other potentially abusable prescription drugs. PMPs are meant to help prevent adverse drug-related events such as opioid overdoses, drug diversion, and substance abuse by decreasing the amount and/or frequency of opioid prescribing, and by identifying those patients who are obtaining prescriptions from multiple providers or those physicians overprescribing opioids.

Indivior is a specialty pharmaceuticals business. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. It is also listed on the NASDAQ Global Select Market.

Founded in 1990, Insys Therapeutics was an American specialty pharmaceutical company based in Chandler, Arizona. Its main product was Subsys, a sublingual liquid form of the drug fentanyl. Fentanyl is an extremely fast-acting and powerful opioid used to relieve peaks of pain in cancer patients.

<span class="mw-page-title-main">Opioid epidemic in the United States</span> Ongoing overuse of opioid medication in the US

There's an ongoing opioid epidemic in the United States, originating out of both medical prescriptions and illegal sources. The epidemic began in the United States in the late 1990s, according to the Centers for Disease Control and Prevention (CDC), when opioids were increasingly prescribed for pain management, resulting in a rise in overall opioid use throughout subsequent years.

Hershel M. Jick was an American medical researcher and associate professor of medicine at Boston University School of Medicine, where he was the director of the Boston Collaborative Drug Surveillance Program.

<span class="mw-page-title-main">Opioid epidemic</span> Deaths due to abuse of opioid drugs

The opioid epidemic, also referred to as the opioid crisis, is the rapid increase in the overuse, misuse/abuse, and overdose deaths attributed either in part or in whole to the class of drugs called opiates/opioids since the 1990s. It includes the significant medical, social, psychological, demographic and economic consequences of the medical, non-medical, and recreational abuse of these medications.

Chinazo D. Opia Cunningham is a physician, researcher, and Professor of Medicine at Albert Einstein College of Medicine in New York City. She is also the Director of Diversity Affairs for the Department of Medicine. She worked on the frontlines during the HIV/AIDS crisis in San Francisco and in 2020 began working on the frontlines of the Coronavirus disease 2019 (COVID-19) pandemic in New York City. She also specializes in treating patients with addiction, overseeing a network using buprenorphine to treat people with opioid addiction.

Opioid agonist therapy (OAT) is a treatment in which prescribed opioid agonists are given to patients who live with Opioid use disorder (OUD). In the case of methadone maintenance treatment (MMT), methadone is used to treat dependence on heroin or other opioids, and is administered on an ongoing basis.

<span class="mw-page-title-main">Prescription drug addiction</span> Medical condition

Prescription drug addiction is the chronic, repeated use of a prescription drug in ways other than prescribed for, including using someone else’s prescription. A prescription drug is a pharmaceutical drug that may not be dispensed without a legal medical prescription. Drugs in this category are supervised due to their potential for misuse and substance use disorder. The classes of medications most commonly abused are opioids, central nervous system (CNS) depressants and central nervous stimulants. In particular, prescription opioid is most commonly abused in the form of prescription analgesics.

<span class="mw-page-title-main">Response to the Opioid Crisis in New Jersey</span> Policy

New Jersey's most recent revised policy was issued September 7, 2022 pursuant to P.L.2021, c.152 which authorized opioid antidotes to be dispensed without a prescription or fee. Its goal is to make opioid antidotes widely available, reducing mortality from overdose while decreasing morbidity in conjunction with sterile needle access, fentanyl test strips, and substance use treatment programs. A $67 million grant provided by the Department of Health and Human Services provides funding for naloxone as well as recovery services. This policy enables any person to distribute an opioid antidote to someone they deem at risk of an opioid overdose, alongside information regarding: opioid overdose prevention and recognition, the administration of naloxone, circumstances that warrant calling 911 for assistance with an opioid overdose, and contraindications of naloxone. Instructions on how to perform resuscitation and the appropriate care of an overdose victim after the administration of an opioid antidote should also be included. Community first aid squads, professional organizations, police departments, and emergency departments are required to "leave-behind" naloxone and information with every person who overdosed or is at risk of overdosing.

In response to the surging opioid prescription rates by health care providers that contributed to the opioid epidemic in the United States, US states began passing legislation to stifle high-risk prescribing practices. These new laws fell primarily into one of the following four categories:

  1. Prescription Drug Monitoring Program (PDMP) enrollment laws: prescribers must enroll in their state's PDMP, an electronic database containing a record of all patients' controlled substance prescriptions
  2. PDMP query laws: prescribers must check the PDMP before prescribing an opioid
  3. Opioid prescribing cap laws: opioid prescriptions cannot exceed designated doses or durations
  4. Pill mill laws: pain clinics are closely regulated and monitored to minimize the prescription of opioids non-medically

References

  1. ↑ "Hadland's leadership expands health care access for teens and young adults". Massachusetts General Hospital. Retrieved 2022-07-09.
  2. ↑ "Boston doctor calls for more accessible, free COVID-19 testing". www.boston.com. Retrieved 2022-07-09.
  3. ↑ "We asked 5 pediatricians every question about kids and Omicron". Fortune. Retrieved 2022-07-09.
  4. 1 2 "When it takes a village . . . and a day care . . . and a taekwondo instructor to raise a child - The Boston Globe". BostonGlobe.com. Retrieved 2022-07-09.
  5. ↑ "Harvard specialists sift damage of pandemic-era drinking". Harvard Gazette. 2022-06-14. Retrieved 2022-07-09.
  6. ↑ Thomas, Katie; Hsu, Tiffany (2019-08-27). "Johnson & Johnson's Brand Falters Over Its Role in the Opioid Crisis". The New York Times. ISSN   0362-4331 . Retrieved 2022-07-09.
  7. 1 2 3 Hadland, Scott E.; Rivera-Aguirre, Ariadne; Marshall, Brandon D. L.; Cerdá, Magdalena (2019-01-18). "Association of Pharmaceutical Industry Marketing of Opioid Products With Mortality From Opioid-Related Overdoses". JAMA Network Open. 2 (1): e186007. doi:10.1001/jamanetworkopen.2018.6007. ISSN   2574-3805. PMC   6484875 . PMID   30657529.
  8. 1 2 Goodnough, Abby (2019-01-18). "Study Links Drug Maker Gifts for Doctors to More Overdose Deaths". The New York Times. ISSN   0362-4331 . Retrieved 2022-01-14.
  9. ↑ Kounang, Nadia (2019-01-18). "With more money spent marketing opioids, more overdose deaths followed, study says". CNN. Retrieved 2022-07-09.
  10. 1 2 Hadland, Scott E.; Cerdá, Magdalena; Li, Yu; Krieger, Maxwell S.; Marshall, Brandon D. L. (2018-06-01). "Association of Pharmaceutical Industry Marketing of Opioid Products to Physicians With Subsequent Opioid Prescribing". JAMA Internal Medicine. 178 (6): 861–863. doi:10.1001/jamainternmed.2018.1999. ISSN   2168-6106. PMC   6145750 . PMID   29799955.
  11. ↑ Lopez, German (2018-05-15). "Drug companies bought doctors fancy meals — and then those doctors prescribed more opioids". Vox. Retrieved 2022-07-09.
  12. ↑ "Founder and Former Chairman of the Board of Insys Therapeutics Sentenced to 66 Months in Prison". www.justice.gov. 2020-01-23. Retrieved 2022-07-09.
  13. ↑ "Drug companies marketing stimulants to doctors can impact prescribing practices, study shows". Boston Herald. 2020-01-24. Retrieved 2022-07-09.
  14. ↑ Earlywine, Joel J.; Hadland, Scott E.; Raifman, Julia (2020-09-25). "State-level prescription drug monitoring program mandates and adolescent injection drug use in the United States, 1995–2017: A difference-in-differences analysis". PLOS Medicine. 17 (9): e1003272. doi: 10.1371/journal.pmed.1003272 . ISSN   1549-1676. PMC   7518580 . PMID   32976539.
  15. ↑ Cohan, Alexi (2019-09-23). "Boston hospitals' study: Docs failing kids addicted to nicotine". Boston Herald. Retrieved 2022-07-09.
  16. ↑ Hadland, Dr Scott. "Back to school: Young kids need COVID testing and lots of it. Why is it so hard to get?". USA TODAY. Retrieved 2022-07-09.
  17. ↑ Hadland, Dr Scott E. "Don't let George Floyd's substance use muddy the facts in Derek Chauvin trial: Addiction doctor". USA TODAY. Retrieved 2022-07-09.
  18. ↑ "Opinion: The other health crisis the stimulus package will help". CNN. 10 March 2021. Retrieved 2022-07-09.
  19. ↑ "How the Child Tax Credit can break cycles of addiction | Opinion". Newsweek. 2021-09-09. Retrieved 2022-07-09.
  20. ↑ New Day With John Berman and Brianna Keilar : CNNW : August 13, 2021 2:59am-4:00am PDT, CNNW, 2021-08-13, retrieved 2022-07-09{{citation}}: CS1 maint: others (link)
  21. ↑ Rothstein, Kevin (2022-05-02). "Mother's warning about fentanyl and teens". WCVB. Retrieved 2022-07-09.
Flag of the United States.svg Scientist.svg Rod of Asclepius2.svg

This biographical article related to a physician in the United States is a stub. You can help Wikipedia by expanding it.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.